Business ❯ Healthcare ❯ Pharmaceuticals

Biotechnology

Acquisitions Pacira BioSciences Cell Therapies Cancer Treatment Clinical Trials Moderna Obesity Treatments Engineering Solutions Regeneron Pharmaceuticals Biogen mRNA Manufacturing Biocon Ltd Cell Therapy Alzheimer's Disease Innovent Biologics Market Competition Avalo Therapeutics Neumora Therapeutics Female Founders Biotech Companies

Ultragenyx Hit With Securities Class Action Over Failed Phase III Trials

Investors have until April 6, 2026 to seek appointment as lead plaintiff in the case.

Eli Lilly to Acquire Orna Therapeutics in Up to $2.4 Billion Bet on In Vivo CAR‑T

Lilly and Innovent Forge Territory-Split Cancer and Immunology Alliance

Merck Reportedly Weighs $28–$32 Billion Deal for Revolution Medicines After AbbVie Denial

Sanofi Secures Global Rights to ADEL’s Alzheimer’s Antibody in Deal Worth Up to $1.04 Billion

Johnson & Johnson to Buy Halda Therapeutics for $3.05 Billion to Bolster Oncology Pipeline

Pfizer Sues Metsera and Novo Nordisk to Block Termination of $4.9 Billion Deal

BioCryst to Acquire Astria in $700 Million Cash-and-Stock Deal to Bolster HAE Portfolio

Moderna Cuts 10% of Global Workforce in Major Cost Overhaul

AbbVie to Acquire Capstan Therapeutics for $2.1 Billion to Boost In Vivo CAR-T Portfolio